Position in RIGL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,901,805
+$6,987,279 QoQ
Shares Held
483,175
+9.7% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. RIGL ranks #140 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RIGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,901,805 | 483,175 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $11,914,526 | 440,626 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,173,368 | 424,314 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,004,072 | 423,723 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,784,318 | 415,607 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $7,396,911 | 411,168 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,762,497 | 402,051 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,466,547 | 399,663 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,212,227 | 390,782 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,612,898 | 3,792,499 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,354,413 | 3,692,699 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,830,868 | 3,547,100 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,395,094 | 3,407,050 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,322,460 | 3,274,591 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,724,205 | 3,149,470 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,641,961 | 3,086,408 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,467,358 | 3,068,459 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,148,586 | 3,059,728 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,248,549 | 3,112,660 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $11,273,110 | 3,105,540 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,929,406 | 2,979,126 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,551,844 | 2,792,937 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $9,101,092 | 2,600,312 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,128,676 | 2,553,615 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,573,863 | 2,499,379 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,796,386 | 2,433,581 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||